KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Quest Diagnostics (DGX) Equity Income (2016 - 2026)

Quest Diagnostics' Equity Income history spans 18 years, with the latest figure at $4.0 million for Q1 2026.

  • On a quarterly basis, Equity Income fell 77.78% to $4.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $28.0 million, a 3.45% decrease, with the full-year FY2025 number at $42.0 million, up 121.05% from a year prior.
  • Equity Income hit $4.0 million in Q1 2026 for Quest Diagnostics, down from $7.0 million in the prior quarter.
  • Over the last five years, Equity Income for DGX hit a ceiling of $31.0 million in Q1 2022 and a floor of $3.0 million in Q4 2022.
  • Historically, Equity Income has averaged $8.4 million across 5 years, with a median of $6.5 million in 2022.
  • Biggest five-year swings in Equity Income: crashed 88.0% in 2022 and later skyrocketed 166.67% in 2023.
  • Tracing DGX's Equity Income over 5 years: stood at $3.0 million in 2022, then skyrocketed by 166.67% to $8.0 million in 2023, then plummeted by 37.5% to $5.0 million in 2024, then soared by 40.0% to $7.0 million in 2025, then crashed by 42.86% to $4.0 million in 2026.
  • Business Quant data shows Equity Income for DGX at $4.0 million in Q1 2026, $7.0 million in Q4 2025, and $8.0 million in Q3 2025.